marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
BioMarin Pharmaceutical Financial Statements 2011-2024 | BMRN
Annual Financial Statements BioMarin Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
16.9 B | 19.1 B | 16.2 B | 15.9 B | 15.3 B | 17.2 B | 15.7 B | 14.2 B | 11.8 B | 14.2 B | 9.58 B | 6.51 B | 3.99 B |
Shares |
188 M | 185 M | 183 M | 181 M | 179 M | 177 M | 174 M | 166 M | 160 M | 146 M | 138 M | 120 M | 112 M |
Historical Prices |
90 | 103 | 88.3 | 87.7 | 84.5 | 85.2 | 89.2 | 82.8 | 105 | 90.4 | 70.3 | 49.2 | 34.4 |
Net Income |
168 M | 142 M | -64.1 M | 854 M | -23.8 M | -77.2 M | -117 M | -630 M | -172 M | -134 M | -176 M | -114 M | -53.8 M |
Revenue |
2.42 B | 2.1 B | 1.85 B | 1.86 B | 1.7 B | 1.49 B | 1.31 B | 1.12 B | 890 M | 751 M | 548 M | 501 M | 441 M |
Cost of Revenue |
515 M | 484 M | 471 M | 524 M | 359 M | 315 M | 242 M | 210 M | 152 M | 122 M | 88.4 M | 91.8 M | 84 M |
Gross Profit |
- | - | - | - | 1.34 B | 1.18 B | 1.07 B | 907 M | 738 M | 621 M | 453 M | 409 M | 357 M |
Operating Income |
158 M | 150 M | -82.3 M | -43.4 M | -100 M | -124 M | -14.7 M | -803 M | -111 M | -92.9 M | -156 M | -110 M | -33.9 M |
Interest Expense |
17.3 M | 16 M | 15.3 M | 29.3 M | 23.5 M | 43.7 M | 42.7 M | 39.5 M | 38.2 M | 36.6 M | 10.4 M | 7.64 M | 8.41 M |
EBITDA |
262 M | 252 M | 25.7 M | 61.7 M | -51.3 M | -125 M | -93.2 M | -231 M | -299 M | -142 M | -137 M | -91.5 M | -32.5 M |
Operating Expenses |
- | - | - | - | 1.47 B | 1.35 B | 1.21 B | 1.11 B | 1.02 B | 782 M | 609 M | 519 M | 391 M |
General and Administrative Expenses |
937 M | 854 M | 759 M | 738 M | 681 M | 604 M | 554 M | 477 M | 402 M | 302 M | 235 M | 198 M | 175 M |
All numbers in USD currency
Quarterly Income Statement BioMarin Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
190 M | 190 M | 189 M | 189 M | 188 M | 188 M | 187 M | 186 M | 186 M | 185 M | 184 M | 184 M | 183 M | 183 M | 182 M | 182 M | 181 M | 181 M | 180 M | 180 M | 179 M | 179 M | 178 M | 178 M | 177 M | 177 M | 176 M | 176 M | 175 M | 174 M | 173 M | 173 M | 168 M | 163 M | 162 M | 162 M | 161 M | 160 M | 158 M | 149 M | 147 M | 146 M | 144 M | 143 M | 141 M | 139 M | 128 M | 126 M | 123 M | 118 M | 115 M | 115 M | 112 M | 111 M | 111 M |
Net Income |
106 M | 107 M | 88.7 M | - | 40.4 M | 56 M | 50.9 M | - | -6.65 M | 27.7 M | 121 M | - | -36.5 M | 12.9 M | 17.4 M | - | 785 M | -29.2 M | 81.4 M | - | 55 M | -37.4 M | -56.5 M | - | -12.6 M | -16.8 M | -44.1 M | - | -12.5 M | -36.8 M | -16.3 M | - | -37.4 M | -419 M | -83.1 M | - | -90.9 M | -82 M | -67.5 M | - | 7.44 M | -33.5 M | -38.1 M | - | -53 M | -21.5 M | -39.8 M | - | -5.36 M | -32 M | -24 M | - | -17.7 M | -5.08 M | -4.37 M |
Revenue |
746 M | 712 M | 649 M | - | 581 M | 595 M | 596 M | - | 505 M | 534 M | 519 M | - | 409 M | 502 M | 486 M | - | 477 M | 429 M | 502 M | - | 461 M | 388 M | 401 M | - | 392 M | 373 M | 373 M | - | 334 M | 317 M | 304 M | - | 280 M | 300 M | 237 M | - | 209 M | 250 M | 203 M | - | 177 M | 192 M | 152 M | - | 137 M | 137 M | 128 M | - | 128 M | 124 M | 117 M | - | 113 M | 111 M | 109 M |
Cost of Revenue |
188 M | 130 M | 125 M | - | 128 M | 131 M | 135 M | - | 116 M | 123 M | 117 M | - | 104 M | 127 M | 120 M | - | 189 M | 98 M | 111 M | - | 96.9 M | 77.4 M | 89.2 M | - | 78.9 M | 79 M | 82.3 M | - | 59.5 M | 56.3 M | 50 M | - | 50.7 M | 51.6 M | 43.1 M | - | 34.9 M | 38.1 M | 31 M | - | 29.9 M | 31.2 M | 22.8 M | - | 28.1 M | 22.6 M | 20.5 M | - | 24.6 M | 23.6 M | 17.1 M | - | 22.4 M | 19.3 M | 20.8 M |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
114 M | 120 M | 88.5 M | - | 30.5 M | 65.6 M | 62.4 M | - | -2.42 M | 39.2 M | 137 M | - | -53.2 M | 11.7 M | 25.1 M | - | -55.9 M | -40.9 M | 105 M | - | 4.01 M | -41.4 M | -54 M | - | -15.7 M | -25.3 M | -44.4 M | - | -13.7 M | -38.8 M | -20.2 M | - | -60.1 M | -573 M | -80.9 M | - | -81.9 M | -64.3 M | -65.9 M | - | 11.2 M | -18.9 M | -26.5 M | - | -50.7 M | -20.1 M | -32.9 M | - | -10.5 M | -31 M | -21.9 M | - | -15.5 M | 768 K | 2.29 M |
Interest Expense |
- | - | 3.55 M | - | 3.78 M | 3.76 M | 3.7 M | - | 4.68 M | 3.86 M | 3.81 M | - | 3.87 M | 3.82 M | 3.8 M | - | 9.6 M | 8.05 M | 6.92 M | - | 2.94 M | 6.87 M | 6.73 M | - | 12.1 M | 12.2 M | 11.6 M | - | 10.9 M | 10 M | 10.1 M | - | 9.98 M | 9.94 M | 9.84 M | - | 9.45 M | 10 M | 9.46 M | - | 9.12 M | 9.22 M | 9.11 M | - | 526 K | 603 K | 1.72 M | - | 1.84 M | 1.92 M | 1.95 M | - | 2.17 M | 2.2 M | 2.16 M |
EBITDA |
125 M | 132 M | 116 M | - | 40.4 M | 75 M | 88.8 M | - | 6.28 M | 48.7 M | 165 M | - | 28.8 M | 23.5 M | 53.1 M | - | 21.9 M | 10.2 M | 131 M | - | 83.5 M | 7.42 M | -31.5 M | - | 55.2 M | 19.3 M | -20.7 M | - | 45.5 M | -315 K | -796 K | - | 16.7 M | -525 M | -62.2 M | - | -47.6 M | -42 M | -55 M | - | 51.1 M | 6.8 M | -14.5 M | - | -13.2 M | 4.16 M | -21.6 M | - | 22.9 M | -9.18 M | -11.3 M | - | 10.9 M | 17.9 M | 10.9 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
253 M | 263 M | 226 M | - | 216 M | 206 M | 211 M | - | 217 M | 197 M | 195 M | - | 183 M | 184 M | 174 M | - | 179 M | 175 M | 187 M | - | 170 M | 161 M | 162 M | - | 149 M | 153 M | 138 M | - | 131 M | 144 M | 120 M | - | 119 M | 110 M | 105 M | - | 94 M | 102 M | 92.8 M | - | 74.6 M | 68.1 M | 60.1 M | - | 61.8 M | 50.7 M | 51 M | - | 46.3 M | 51.5 M | 45.2 M | - | 44.9 M | 41 M | 41 M |
All numbers in USD currency